These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Exosurf rescue surfactant improves high ventilation-perfusion mismatch in respiratory distress syndrome.
    Author: Billman D, Nicks J, Schumacher R.
    Journal: Pediatr Pulmonol; 1994 Nov; 18(5):279-83. PubMed ID: 7898965.
    Abstract:
    OBJECTIVE: To assess ventilation/perfusion (VA/Q) mismatch of the high type, following rescue surfactant therapy for respiratory distress syndrome. HYPOTHESIS: Surfactant therapy reduces such mismatch. DESIGN: Randomized, double-blind, placebo-controlled study, assessing VA/Q with the arterial-alveolar difference of CO2 tension (P(a-A)CO2). This difference was determined with capnometry and arterial blood gases, using the equation: P(a-A)CO2 equals arterial CO2 minus alveolar CO2 partial pressure. SETTING: A level III nursery. PATIENTS: Ten intubated infants with respiratory distress syndrome. INTERVENTION: Infants were randomized to each receive two doses of surfactant or two doses of air placebo. RESULTS: P(a-A)CO2 improved after surfactant and worsened after placebo (P = 0.0021), comparing slopes of 12-hr regression lines. A similar pattern occurred with oxygenation. These changes in P(a-A)CO2 and in oxygenation were minimally correlated within the surfactant group. CONCLUSION: Exosurf rescue surfactant reduced VA/Q mismatch of the high type, over several hours.
    [Abstract] [Full Text] [Related] [New Search]